Novel N-propylphthalimide- and 4-vinylbenzyl-substituted benzimidazole salts: Synthesis, characterization, and determination of their metal chelating effects and inhibition profiles against acetylcholinesterase and carbonic anhydrase enzymes
dc.authorid | Aktaş, Aydın/0000-0001-8496-6782 | |
dc.authorid | Gulcin, ilhami/0000-0001-5993-1668 | |
dc.authorid | Taslimi, Parham/0000-0002-3171-0633 | |
dc.authorwosid | Aktaş, Aydın/J-6194-2019 | |
dc.authorwosid | Gulcin, ilhami/F-1428-2014 | |
dc.authorwosid | Taslimi, Parham/AAL-2788-2020 | |
dc.authorwosid | Gök, Yetkin/AAA-5669-2021 | |
dc.contributor.author | Sari, Yakup | |
dc.contributor.author | Aktas, Aydin | |
dc.contributor.author | Taslimi, Parham | |
dc.contributor.author | Gok, Yetkin | |
dc.contributor.author | Gulcin, Ilhami | |
dc.date.accessioned | 2024-08-04T20:44:06Z | |
dc.date.available | 2024-08-04T20:44:06Z | |
dc.date.issued | 2018 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | The novel N-propylphthalimide-substituted and 4-vinylbenzyl-substituted N-heterocyclic carbene (NHC) precursors were synthesized by N-substituted benzimidazolium with aryl halides. The novel N-propylphthalimide-substituted and 4-vinylbenzyl-substituted NHC precursors have been characterized by using H-1 NMR, C-13 NMR, FTIR spectroscopy, and elemental analysis techniques. They were tested for the inhibition of AChE and hCA enzymes and demonstrated efficient inhibition profiles with K-i values in the range of 351.0-1269.9 nM against hCA I, 346.6-1193.1 nM against hCA II, and 19.0-76.3 nM against AChE. On the other hand, acetazolamide, a clinically used molecule, utilized as CA inhibitor, obtained a K-i value of 1246.7 nM against hCA I and 1407.6 nM against hCA II. Additionally, tacrine inhibited AChE and obtained a K-i value of 174.6 nM. | en_US |
dc.identifier.doi | 10.1002/jbt.22009 | |
dc.identifier.issn | 1095-6670 | |
dc.identifier.issn | 1099-0461 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 29149534 | en_US |
dc.identifier.scopus | 2-s2.0-85034266466 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1002/jbt.22009 | |
dc.identifier.uri | https://hdl.handle.net/11616/98032 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000419943200011 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Journal of Biochemical and Molecular Toxicology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | acetylcholinesterase | en_US |
dc.subject | benzimidazole | en_US |
dc.subject | carbonic anhydrase | en_US |
dc.subject | metal chelating | en_US |
dc.subject | N-heterocyclic carbene precursors | en_US |
dc.title | Novel N-propylphthalimide- and 4-vinylbenzyl-substituted benzimidazole salts: Synthesis, characterization, and determination of their metal chelating effects and inhibition profiles against acetylcholinesterase and carbonic anhydrase enzymes | en_US |
dc.type | Article | en_US |